Article Information
History
- June 20, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Slade Decker, BS2,
- Shaoming Xiao, MSPH2,
- Carly Dillen, PhD3,
- Christina M. Schumacher, PhD, MHS2,
- Aaron M. Milstone, MD, MHS1,2,
- Matthew Frieman, PhD3 and
- Amanda K. Debes, PhD, MS1,*
- 1Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
- 2Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 3Center for Pathogen Research, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore MD 21212
- ↵*Correspondence:
Amanda K. Debes PhD, MS Department of International Health 615 N. Wolfe Street, E5036 Baltimore, MD 21205 adebes1{at}jhu.edu
Posted June 20, 2023.
Association of Nirmatrelvir/Ritonavir treatment and COVID-19 neutralizing antibody titers in a longitudinal healthcare worker cohort
